Stage-Related Alterations in Kidney Cancer
Author Information
Author(s): Heike Junker, Simone Venz, Uwe Zimmermann, Andrea Thiele, Christian Scharf, Reinhard Walther
Primary Institution: University of Greifswald
Hypothesis
To identify potential progression markers for kidney cancer by examining non-neoplastic and neoplastic kidney tissue from different tumor stages.
Conclusion
The study identified 187 different proteins with stage-related alterations in kidney cancer, which may serve as potential biomarkers for diagnosis and therapy.
Supporting Evidence
- 176 spots were detected as at least 2-fold differentially expressed.
- Principal Component Analysis allowed robust quality control and classification of samples.
- Immunohistochemistry revealed correlations between selected proteins and tumor grading.
Takeaway
The researchers looked at kidney cancer tissues to find proteins that change with the cancer's progression, which could help doctors diagnose and treat the disease better.
Methodology
The study used 2D-DIGE and MALDI-ToF-MS/MS to analyze protein expression in kidney cancer tissues from different tumor stages.
Potential Biases
Potential biases may arise from the selection of tissue samples and the methods used for protein analysis.
Limitations
The study may not account for all variables affecting protein expression in kidney cancer due to tumor heterogeneity.
Participant Demographics
The study included 27 kidney cancer patients and 9 control subjects, with varying tumor stages and grades.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website